Free Trial
NASDAQ:PRE

Prenetics Global (PRE) Stock Price, News & Analysis

Prenetics Global logo
$7.98 -0.09 (-1.05%)
Closing price 03:58 PM Eastern
Extended Trading
$7.98 0.00 (0.00%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Prenetics Global Stock (NASDAQ:PRE)

Key Stats

Today's Range
$7.64
$8.16
50-Day Range
$5.25
$11.23
52-Week Range
$3.09
$11.99
Volume
25,491 shs
Average Volume
22,823 shs
Market Capitalization
$97.30 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.00
Consensus Rating
Buy

Company Overview

Prenetics Global Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
37th Percentile Overall Score

PRE MarketRank™: 

Prenetics Global scored higher than 37% of companies evaluated by MarketBeat, and ranked 731st out of 933 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Prenetics Global has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Prenetics Global has received no research coverage in the past 90 days.

  • Read more about Prenetics Global's stock forecast and price target.
  • Earnings Growth

    Earnings for Prenetics Global are expected to grow in the coming year, from ($3.30) to ($2.08) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Prenetics Global is -2.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Prenetics Global is -2.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Prenetics Global has a P/B Ratio of 0.57. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Prenetics Global's valuation and earnings.
  • Percentage of Shares Shorted

    0.71% of the float of Prenetics Global has been sold short.
  • Short Interest Ratio / Days to Cover

    Prenetics Global has a short interest ratio ("days to cover") of 1.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Prenetics Global has recently increased by 85.41%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Prenetics Global does not currently pay a dividend.

  • Dividend Growth

    Prenetics Global does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.71% of the float of Prenetics Global has been sold short.
  • Short Interest Ratio / Days to Cover

    Prenetics Global has a short interest ratio ("days to cover") of 1.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Prenetics Global has recently increased by 85.41%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Prenetics Global has a news sentiment score of 1.42. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.94 average news sentiment score of Medical companies.
  • Search Interest

    8 people have searched for PRE on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Prenetics Global insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 7.80% of the stock of Prenetics Global is held by insiders.

  • Percentage Held by Institutions

    Only 25.01% of the stock of Prenetics Global is held by institutions.

  • Read more about Prenetics Global's insider trading history.
Receive PRE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Prenetics Global and its competitors with MarketBeat's FREE daily newsletter.

PRE Stock News Headlines

PRE Prenetics Global Limited - Seeking Alpha
Prenetics Global Limited (PRE) - Yahoo Finance
Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
See More Headlines

PRE Stock Analysis - Frequently Asked Questions

Prenetics Global's stock was trading at $5.80 at the start of the year. Since then, PRE shares have increased by 37.5% and is now trading at $7.9750.

Prenetics Global Limited (NASDAQ:PRE) issued its quarterly earnings data on Thursday, June, 12th. The company reported ($0.80) earnings per share for the quarter. The firm earned $17.31 million during the quarter. Prenetics Global had a negative net margin of 115.91% and a negative trailing twelve-month return on equity of 28.07%.

Prenetics Global shares reverse split before market open on Tuesday, November 14th 2023.The 1-15 reverse split was announced on Wednesday, November 1st 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, November 13th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Shares of PRE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Prenetics Global investors own include Arista Networks (ANET), Adobe (ADBE), Broadcom (AVGO), NVIDIA (NVDA), Intuit (INTU), Arch Capital Group (ACGL) and Celestica (CLS).

Company Calendar

Last Earnings
6/12/2025
Today
7/18/2025
Next Earnings (Estimated)
10/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Measuring And Control Equipment
Current Symbol
NASDAQ:PRE
CIK
1876431
Fax
N/A
Employees
1
Year Founded
N/A

Price Target and Rating

High Price Target
$9.00
Low Price Target
$9.00
Potential Upside/Downside
+12.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
($3.99)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$46.30 million
Net Margins
-115.91%
Pretax Margin
-143.22%
Return on Equity
-28.07%
Return on Assets
-22.27%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.07
Quick Ratio
1.89

Sales & Book Value

Annual Sales
$30.62 million
Price / Sales
3.18
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$14.04 per share
Price / Book
0.57

Miscellaneous

Outstanding Shares
12,200,000
Free Float
11,253,000
Market Cap
$97.30 million
Optionable
Not Optionable
Beta
0.15
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:PRE) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners